BioPharma Pharma Research
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the ...
July 02, 2021 | News
Pall Corporation, a global leader in filtration, separation and purification, today announced a new contract worth more than $7M with full-service contract...
July 01, 2021 | News
OnCusp successfully closed its seed round financing of $25 million on April 1, 2021, led by Sequoia Capital and Biotrack Capital, followed b...
July 01, 2021 | News
Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate t...
June 30, 2021 | News
Evonik now offers ‘Chemistry in Water’, to enable classical organic reactions to be performed in water New technology allows drug manufactur...
June 30, 2021 | News
Körber and Immunotech Biopharm will implement Werum PAS-X MES in a greenfield cell & gene site in Beijing. This step is an important milestone to ...
June 29, 2021 | News
Opaganib's unique, orally-administered, host-targeted, dual antiviral and anti-inflammatory approach to combatting COVID-19 is also expected to maintain ef...
June 29, 2021 | News
To Realize Compact and Low-cost Proton Therapy System - B dot Medical Inc. has confirmed the superconductivity of a superconducting be...
June 28, 2021 | News
Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture CYFIRMA, a threat discovery and cyb...
June 25, 2021 | News
The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in China Individualized living-cell-based medicine: genetica...
June 24, 2021 | News
Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using World's Fastest Supercomputer with Researchers of Research Center for Advanced Science...
June 22, 2021 | News
Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies...
June 21, 2021 | News
In contrast, non-viral delivery systems are expected to have a better safety profile and with simplified manufacturing, offer the potential for a templated...
June 18, 2021 | News | By Nargisse El Hajjami, Dr1, Manuel Brantner, Mag.2, Anissa Boumlic, Dr3, Shiksha Mantri, 4, Bahar Cebi, 5 1Associate Director Cell and Gene Therapy Segment EMEA, 2Associate Director Vaccine and Plasma Segment EMEA, 3Head of Global Vaccine & Plasma Segments
Therapies developed on the Illuminox platform involve administering a targeting moiety conjugated with one or more dyes, which is illuminated by light at a...
June 18, 2021 | News
Most Read
Bio Jobs
News
Editor Picks